A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations
Endeavor Biomedicines, Inc.
Endeavor Biomedicines, Inc.
Masonic Cancer Center, University of Minnesota
University of Iowa
University of Alberta
University of Iowa
University of Iowa
GE Healthcare
University of Iowa
National Cancer Institute (NCI)
Children's Oncology Group
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Children's Hospital Medical Center, Cincinnati